BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

5578

543349

ACUTAAS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ACUTAAS CHEMICALS LIMITED performance

Today’s low

Today’s high

₹ 1149.90 ₹ 1159.50
₹ 1148.20

52 week low

52 week high

₹ 607.50 ₹ 1322.00
₹ 1148.20

Open Price

₹ 1158.90

Prev. Close

₹ 1148.20

Volume (Shares)

387401.00

Total traded value

₹ 4448.13

Upper Circuit

₹ 1377.80

Lower Circuit

₹ 918.60

info

ACUTAAS CHEMICALS LIMITED Share Price Update

As of the latest trading session, ACUTAAS CHEMICALS LIMITED share price is currently at ₹ 1156, which is up by ₹ 7.80 from its previous closing. Today, the stock has fluctuated between ₹ 1149.90 and ₹ 1159.50. Over the past year, ACUTAAS CHEMICALS LIMITED has achieved a return of 67.71 %. In the last month alone, the return has been 4.99 %. Read More...

Investment Returns

Over 1 Month 4.99% Over 3 Months -2.37% Over 6 Months 13.30% Over 1 Year 67.71%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ACUTAAS CHEMICALS LIMITED fundamentals


  • Market cap (Cr)

    9,400.20

  • P/E Ratio (TTM)

    58.94

  • Beta

    1.66

  • Book Value / share

    160.20

  • Return on equity

    9.36%

  • EPS (TTM)

    19.49

  • Dividend yield

    0.13%

  • Net profit/quarter (Cr)

    62.85

info icon alternate text
  • Market cap (Cr)

    9,227.40

  • P/E Ratio (TTM)

    58.94

  • Beta

    1.59

  • Book Value / share

    160.20

  • Return on equity

    9.36%

  • EPS (TTM)

    19.49

  • Dividend yield

    0.13%

  • Net profit/quarter (Cr)

    62.85

info icon alternate text

ACUTAAS CHEMICALS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 304.16
Operating Expense 227.04
Net Profit 62.85
Net Profit Margin (%) 20.66
Earnings Per Share (EPS) 7.84
EBITDA 89.75
Effective Tax Rate (%) 24.11
Particulars DEC 2024 (Values in Cr)
Revenue 270.94
Operating Expense 210.57
Net Profit 45.31
Net Profit Margin (%) 16.72
Earnings Per Share (EPS) 11.31
EBITDA 68.82
Effective Tax Rate (%) 27.56
Particulars SEP 2024 (Values in Cr)
Revenue 243.59
Operating Expense 202.15
Net Profit 37.68
Net Profit Margin (%) 15.46
Earnings Per Share (EPS) 9.41
EBITDA 56.71
Effective Tax Rate (%) 24.67
Particulars JUN 2024 (Values in Cr)
Revenue 171.14
Operating Expense 154.83
Net Profit 13.72
Net Profit Margin (%) 8.01
Earnings Per Share (EPS) 3.43
EBITDA 28.19
Effective Tax Rate (%) 24.67
Particulars MAR 2024 (Values in Cr)
Revenue 219.94
Operating Expense 186.21
Net Profit 32.08
Net Profit Margin (%) 14.58
Earnings Per Share (EPS) 8.75
EBITDA 48.71
Effective Tax Rate (%) 24.14
Particulars MAR 2025 (Values in Cr)
Revenue 989.83
Operating Expense 794.60
Net Profit 159.55
Net Profit Margin (%) 16.11
Earnings Per Share (EPS) 19.91
EBITDA 243.49
Effective Tax Rate (%) 25.29
Particulars MAR 2024 (Values in Cr)
Revenue 687.58
Operating Expense 600.50
Net Profit 43.68
Net Profit Margin (%) 6.35
Earnings Per Share (EPS) 11.91
EBITDA 89.69
Effective Tax Rate (%) 36.78
Particulars MAR 2023 (Values in Cr)
Revenue 616.73
Operating Expense 508.82
Net Profit 83.34
Net Profit Margin (%) 13.51
Earnings Per Share (EPS) 22.87
EBITDA 126.97
Effective Tax Rate (%) 25.73
Particulars MAR 2022 (Values in Cr)
Revenue 520.14
Operating Expense 431.45
Net Profit 71.95
Net Profit Margin (%) 13.83
Earnings Per Share (EPS) 21.03
EBITDA 107.94
Effective Tax Rate (%) 21.32
Particulars MAR 2021 (Values in Cr)
Revenue 340.61
Operating Expense 270.21
Net Profit 54.00
Net Profit Margin (%) 15.85
Earnings Per Share (EPS) 17.14
EBITDA 81.54
Effective Tax Rate (%) 24.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 182.75
ROE % 10.67
ROCE % 16.07
Total Debt to Total Equity 0.17
EBITDA Margin 18.92
Particulars MAR 2023 (Values in Cr)
Book Value / Share 163.01
ROE % 14.92
ROCE % 20.43
Total Debt to Total Equity 0.00
EBITDA Margin 20.58
Particulars MAR 2022 (Values in Cr)
Book Value / Share 143.34
ROE % 20.88
ROCE % 23.54
Total Debt to Total Equity 0.20
EBITDA Margin 20.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 52.99
ROE % 38.75
ROCE % 32.12
Total Debt to Total Equity 0.70
EBITDA Margin 23.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 106.49
ROE % 28.32
ROCE % 25.95
Total Debt to Total Equity 0.58
EBITDA Margin 18.30
Particulars MAR 2024 (Values in Cr)
Book Value / Share 183.05
ROE % 9.36
ROCE % 13.51
Total Debt to Total Equity 0.16
EBITDA Margin 16.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 161.04
ROE % 15.09
ROCE % 20.65
Total Debt to Total Equity 0.00
EBITDA Margin 20.59
Particulars MAR 2022 (Values in Cr)
Book Value / Share 142.16
ROE % 21.10
ROCE % 23.75
Total Debt to Total Equity 0.20
EBITDA Margin 20.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 52.05
ROE % 39.72
ROCE % 32.58
Total Debt to Total Equity 0.72
EBITDA Margin 23.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 102.84
ROE % 29.05
ROCE % 26.37
Total Debt to Total Equity 0.60
EBITDA Margin 18.30
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 53.31
Total Assets 1095.90
Total Liabilities 1095.90
Total Equity 682.75
Share Outstanding 36880562
Price to Book Ratio 5.98
Return on Assets (%) 3.90
Return on Capital (%) 4.76
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.67
Total Assets 766.93
Total Liabilities 766.93
Total Equity 593.95
Share Outstanding 36437062
Price to Book Ratio 5.52
Return on Assets (%) 10.86
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 99.55
Total Assets 658.88
Total Liabilities 658.88
Total Equity 522.27
Share Outstanding 36437062
Price to Book Ratio 7.03
Return on Assets (%) 10.91
Return on Capital (%) 13.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.68
Total Assets 413.26
Total Liabilities 413.26
Total Equity 166.93
Share Outstanding 31500000
Price to Book Ratio 0.00
Return on Assets (%) 13.06
Return on Capital (%) 17.79
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.82
Total Assets 231.89
Total Liabilities 231.89
Total Equity 111.81
Share Outstanding 10500000
Price to Book Ratio 0.00
Return on Assets (%) 11.84
Return on Capital (%) 16.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 31.94
Total Assets 1071.25
Total Liabilities 1071.25
Total Equity 675.11
Share Outstanding 36880562
Price to Book Ratio 5.98
Return on Assets (%) 4.07
Return on Capital (%) 4.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.61
Total Assets 759.46
Total Liabilities 759.46
Total Equity 586.78
Share Outstanding 36437062
Price to Book Ratio 5.52
Return on Assets (%) 10.97
Return on Capital (%) 14.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 98.91
Total Assets 654.60
Total Liabilities 654.60
Total Equity 518.00
Share Outstanding 36437062
Price to Book Ratio 7.03
Return on Assets (%) 10.99
Return on Capital (%) 13.87
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.55
Total Assets 410.28
Total Liabilities 410.28
Total Equity 163.95
Share Outstanding 31500000
Price to Book Ratio 0.00
Return on Assets (%) 13.16
Return on Capital (%) 17.96
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.27
Total Assets 228.03
Total Liabilities 228.03
Total Equity 107.97
Share Outstanding 10500000
Price to Book Ratio 0.00
Return on Assets (%) 12.04
Return on Capital (%) 16.98
Particulars MAR 2024 (Values in Cr)
Net Income 81.90
Cash from Operations 149.51
Cash from Investing -365.39
Cash from Financing 239.36
Net change in Cash -0.86
Free Cash Flow 430.42
Particulars MAR 2023 (Values in Cr)
Net Income 112.17
Cash from Operations 89.98
Cash from Investing -33.04
Cash from Financing -12.25
Net change in Cash 20.23
Free Cash Flow 168.33
Particulars MAR 2022 (Values in Cr)
Net Income 91.45
Cash from Operations 10.87
Cash from Investing -120.71
Cash from Financing 140.26
Net change in Cash 7.61
Free Cash Flow 44.63
Particulars MAR 2021 (Values in Cr)
Net Income 71.72
Cash from Operations 42.13
Cash from Investing -101.20
Cash from Financing 72.10
Net change in Cash -1.13
Free Cash Flow 149.25
Particulars MAR 2020 (Values in Cr)
Net Income 34.75
Cash from Operations 35.48
Cash from Investing -23.94
Cash from Financing 0.19
Net change in Cash 3.32
Free Cash Flow 57.09
Particulars MAR 2024 (Values in Cr)
Net Income 69.10
Cash from Operations 116.96
Cash from Investing -337.35
Cash from Financing 235.48
Net change in Cash -1.02
Free Cash Flow 391.24
Particulars MAR 2023 (Values in Cr)
Net Income 112.22
Cash from Operations 80.18
Cash from Investing -20.47
Cash from Financing -14.43
Net change in Cash 20.81
Free Cash Flow 145.85
Particulars MAR 2022 (Values in Cr)
Net Income 91.45
Cash from Operations 13.12
Cash from Investing -122.46
Cash from Financing 140.26
Net change in Cash 8.10
Free Cash Flow 45.91
Particulars MAR 2021 (Values in Cr)
Net Income 71.72
Cash from Operations 41.09
Cash from Investing -100.73
Cash from Financing 72.10
Net change in Cash -1.71
Free Cash Flow 145.51
Particulars MAR 2020 (Values in Cr)
Net Income 34.75
Cash from Operations 35.65
Cash from Investing -24.48
Cash from Financing 0.19
Net change in Cash 2.95
Free Cash Flow 55.36
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 35.90 31.77 1.96 275.11 34.11 / 73.95
BLISS GVS PHARMA LTD 153.10 19.16 1.53 1614.37 105.05 / 184.95
CIPLA LTD 1484.60 23.31 3.84 119918.75 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 393.90 15.08 3.19 1159.29 198.05 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 35.90 92.05 5.67 275.11 34.11 / 73.95
AMRUTAJAN HEALTH LTD 717.85 40.83 6.35 2075.35 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9184.60 131.17 29.80 22961.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD 153.10 23.37 1.52 1614.37 105.05 / 184.95

ACUTAAS CHEMICALS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1148.20 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 1136.50
  • 26 Days 1124.40
  • 10 Days 1128.50
  • 50 Days 1128.90
  • 12 Days 1126.70
  • 100 Days 1118.70
  • 20 Days 1124.00
  • 200 Days 1048.60
1142.23 PIVOT

First Support

1128.57

First Resistance

1160.07

Second Support

1110.73

Second Resistance

1173.73

Third Support

1097.07

Third Resistance

1191.57

RSI

55.36

ADX

8.09

MACD

0.30

Williams % R

-20.55

Commodity Channel Index (CCI)

129.53

Date

2025-07-11

Week

183420.00

Same Day

306770.00

Month

212864.00

1 Year

1.66

3 Year

1.15

Over 1 Month

4.99%

down

Over 1 Year

67.71%

down

Over 3 Months

-2.37%

down

Over 3 Years

30.05%

down

Over 6 Months

13.30%

down

Over 5 Years

0.00%

down

ACUTAAS CHEMICALS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
29.24%
Promoter Holdings
35.95%
FII
16.48%
DII
18.31%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Nareshkumar Ramjibhai Patel 7916124.0 (19.34%) Shareholding of Promoter and Promoter Group
Vaghasia Chetankumar Chhaganlal 6803500.0 (16.62%) Shareholding of Promoter and Promoter Group
Sbi Large & Midcap Fund 1732265.0 (4.23%) Public Shareholding
Dhwani Girishkumar Chovatia 1369516.0 (3.35%) Public Shareholding
Government Pension Fund Global 1372763.0 (3.35%) Public Shareholding
Axis Max Life Insurance Limited A/c - Ulif01311/02/08lifehighgr104 - High Growth Fund 1064622.0 (2.6%) Public Shareholding
Quant Mutual Fund - Quant Active Fund 784755.0 (1.92%) Public Shareholding
Government Of Singapore 772565.0 (1.89%) Public Shareholding
Ashish Kacholia 704974.0 (1.72%) Public Shareholding
Bank Of India Small Cap Fund 648484.0 (1.58%) Public Shareholding
Ashoka Whiteoak Icav - Ashoka Whiteoak India Opportunities Fund 528045.0 (1.29%) Public Shareholding
Vanaja Sundar Iyer 475000.0 (1.16%) Public Shareholding
Malabar India Fund Limited 437258.0 (1.07%) Public Shareholding
Bhanuben Chhaganbhai Vaghasia 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chhagan Ramjibhai Vaghasia 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Parulben Vaghasia 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sheetalben N Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Gevriya Nileshkumar Bhikhubhai 5.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ACUTAAS CHEMICALS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
13 Sep 2024 3.0 Final 13 Sep 2024 Equity shares
18 Sep 2023 3.0 Final 18 Sep 2023 Equity shares
29 Jul 2022 3.0 Final 01 Aug 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
25 Apr 2025 10.0 5.0 25 Apr 2025
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
13 Sep 2024 3.0 Final 13 Sep 2024 Equity shares
18 Sep 2023 3.0 Final 18 Sep 2023 Equity shares
29 Jul 2022 3.0 Final 01 Aug 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
25 Apr 2025 10.0 5.0 25 Apr 2025

ACUTAAS CHEMICALS LIMITED Share Price

Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007. Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018.

The Company is engaged in business of drugs intermediate chemicals and related activities. The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015. It increased warehouse capacity, equipped with modern infrastructure & a storage capacity of 1,050 MT of RM in 2017.

The Company commenced its new Solvent Recovery Plant at Sachin in 2020. It acquired two units namely, the Ankleshwar and Jhagadia units from Gujarat Organics Limited (GOL) in 2021.

The Company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders, mopped up with a total of Rs 570 crore through its public issue in September, 2021.

The Company incorporated wholly owned subsidiary Ami Organics Electrolytes Private Limited in 2023. The Company further embarked on setting brownfield project at Ankleshwar entailing a capex of Rs. 1900 Million. The existing Ankleshwar facility was demolished and work started to set up a new plant with advance technology for pharma intermediates business, scheduled to have installed capacity of 436.5 KL.

The Company acquired a 55% stake in Baba Fine Chemicals (BFC) in FY 2024. A state-of-the-art technology driven plant in Ankleshwar Unit with the total reactor capacity of 442 KL dedicated for manufacture of advanced pharmaceutical intermediate business was established.

Parent organization Indian Private
NSE symbol ACUTAAS
Founded 2007
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Acutaas Chemicals Ltd?

Answer Field

Acutaas Chemicals Ltd share price is for NSE ₹ 1,156.00 & for BSE ₹ 1,156.00 as on Jul 15 2025 09:29 AM.

What is the Market Cap of Acutaas Chemicals Ltd Share?

Answer Field

The market cap of Acutaas Chemicals Ltd for NSE ₹ 4,263.39 & for BSE ₹ 4,263.39 as on Jul 15 2025 09:29 AM.

What is the 52 Week High and Low of Acutaas Chemicals Ltd?

Answer Field

The 52 Week High and Low of Acutaas Chemicals Ltd for NSE is ₹ 1,322.00 and ₹ 607.50 and for BSE is ₹ 1,321.75 and ₹ 0.00.

What is 1 year return for Acutaas Chemicals Ltd?

Answer Field

The 1 year returns on the stock has been 67.71%.

What is the P/E Ratio of Acutaas Chemicals Ltd Share?

Answer Field

As on Jul 15 2025 09:29 AM the price-to-earnings (PE) ratio for Acutaas Chemicals Ltd share is 58.94.

What is the PB ratio of Acutaas Chemicals Ltd Share?

Answer Field

As on Jul 15 2025 09:29 AM, the price-to-book (PB) ratio for Acutaas Chemicals Ltd share is 160.20.

How to Buy Acutaas Chemicals Ltd Share?

Answer Field

You can trade in Acutaas Chemicals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Acutaas Chemicals Ltd Share on Bajaj Broking App?

Answer Field

To buy Acutaas Chemicals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Acutaas Chemicals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|